Related Experiment Video
Updated: Apr 23, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages
Andreas Dander, Matthias Baldauf, Michael Sperk
1Division for Bioinformatics, Biocenter, Innsbruck Medical University, Innrain 80-82, 6020 Innsbruck, Austria. zlatko.trajanoski@i-med.ac.at.
Background:
Cancer immunotherapy has recently entered a remarkable renaissance phase with the approval of several agents for treatment. Cancer treatment platforms have demonstrated profound tumor regressions including complete cure in patients with metastatic cancer. Moreover, technological advances in next-generation sequencing (NGS) as well as the development of devices for scanning whole-slide bioimages from tissue sections and image analysis software for quantitation of tumor-infiltrating lymphocytes (TILs) allow, for the first time, the development of personalized cancer immunotherapies that target patient specific mutations. However, there is currently no bioinformatics solution that supports the integration of these heterogeneous datasets.
Results:
We have developed a bioinformatics platform - Personalized Oncology Suite (POS) - that integrates clinical data, NGS data and whole-slide bioimages from tissue sections. POS is a web-based platform that is scalable, flexible and expandable. The underlying database is based on a data warehouse schema, which is used to integrate information from different sources. POS stores clinical data, genomic data (SNPs and INDELs identified from NGS analysis), and scanned whole-slide images. It features a genome browser as well as access to several instances of the bioimage management application Bisque. POS provides different visualization techniques and offers sophisticated upload and download possibilities. The modular architecture of POS allows the community to easily modify and extend the application.
Conclusions:
The web-based integration of clinical, NGS, and imaging data represents a valuable resource for clinical researchers and future application in medical oncology. POS can be used not only in the context of cancer immunology but also in other studies in which NGS data and images of tissue sections are generated. The application is open-source and can be downloaded at http://www.icbi.at/POS.
Insights
A new bioinformatics platform, Personalized Oncology Suite (POS), integrates clinical, next-generation sequencing (NGS), and whole-slide bioimage data for personalized cancer immunotherapy research. This open-source tool enhances data analysis for oncology studies.
Area of Science:
- Bioinformatics
- Computational Biology
- Oncology
Background:
- Cancer immunotherapy has advanced significantly with new treatments showing promising results.
- Technological progress in next-generation sequencing (NGS) and whole-slide bioimaging enables personalized cancer therapies.
- A gap exists in bioinformatics solutions for integrating diverse datasets like clinical, genomic, and imaging data.
Purpose of the Study:
- To develop a bioinformatics platform for integrating heterogeneous cancer-related datasets.
- To create a solution supporting personalized cancer immunotherapy development.
- To provide a flexible and expandable platform for clinical researchers.
Main Methods:
- Development of the Personalized Oncology Suite (POS), a web-based bioinformatics platform.
- Implementation of a data warehouse schema for integrating clinical, NGS (SNPs, INDELs), and whole-slide bioimages.
- Inclusion of a genome browser and bioimage management application (Bisque).
Main Results:
- POS successfully integrates clinical, genomic, and imaging data into a unified platform.
- The platform offers visualization tools, data upload/download capabilities, and a modular architecture.
- POS is scalable, flexible, and expandable for community modification and extension.
Conclusions:
- Web-based integration of clinical, NGS, and imaging data is a valuable resource for oncology research.
- POS supports personalized cancer immunotherapy and other studies involving NGS and tissue imaging.
- The open-source POS platform is available for download and further development.
More Related Videos
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
13:01Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022